Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China
Open Access
- 11 February 2020
- preprint content
- retracted article
- Published by Cold Spring Harbor Laboratory
Abstract
Background: The ongoing outbreak of the 2019 novel coronavirus (2019-nCoV) in China has led to the declaration of Public Health Emergency of International Concern by the World Health Organization. Methods: All 2019-nCoV infected patients reported to Chinese Center for Disease Control and Prevention up to 26 January 2020 were included for analysis. Disease and death incidence were compared between demographic groups and baseline conditions. Case fatality rates (CFRs) and the basic reproductive number R0 was estimated with a transmission model. Results: As of 26 January 2020, a total of 8866 patients including 4021 (45.35%) laboratory confirmed patients were reported from 30 provinces. Nearly half of the patients were aged 50 years or older (47.7%). There was a clear gender difference in incidence with 0.31 (male) vs. 0.27 (female) per 100,000 people (P<0.001). The median incubation period was 4.75 (interquartile range: 3.0-7.2) days. About 25.5%, 69.9% and 4.5% patients were diagnosed with severe pneumonia, mild pneumonia, and non-pneumonia, respectively. The overall CFR was estimated be 3.06% (95% CI 2.02-4.59%), but male patients, ≥60 years old, baseline diagnosis of severe pneumonia and delay in diagnosis were associated with substantially elevated CFR. The R0 was estimated to be 3.77 (95% CI 3.51-4.05), ranging 2.23-4.82 in sensitivity analyses varying the incubation and infectious periods. Conclusions: Compared with SARS-CoV, 2019-nCoV had comparable transmissibility and lower CFR. Our findings based on individual-level surveillance data emphasize the importance of early detection of elderly patients, particularly males, before symptoms progress to severe pneumonia.Keywords
This publication has 17 references indexed in Scilit:
- A Novel Coronavirus from Patients with Pneumonia in China, 2019The New England Journal of Medicine, 2020
- Recent advances in the detection of respiratory virus infection in humansJournal of Medical Virology, 2020
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoVNature Communications, 2020
- Comparing nonpharmaceutical interventions for containing emerging epidemicsProceedings of the National Academy of Sciences of the United States of America, 2017
- A New Framework and Software to Estimate Time-Varying Reproduction Numbers During EpidemicsAmerican Journal of Epidemiology, 2013
- The Transmissibility and Control of Pandemic Influenza A (H1N1) VirusScience, 2009
- Design and Evaluation of Prophylactic Interventions Using Infectious Disease Incidence Data from Close Contact GroupsJournal of the Royal Statistical Society Series C: Applied Statistics, 2006
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004
- The Statistical Analysis of Failure Time DataJournal of the American Statistical Association, 2003
- Clinical presentations and outcome of severe acute respiratory syndrome in childrenThe Lancet, 2003